Omega Therapeutics logo

Omega Therapeutics Share Price (NASDAQ: OMGA)

-0.16

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 21 Feb 2025

Check the interactive Omega Therapeutics Stock chart to analyse performance

Omega Therapeutics Key Stats

Check Omega Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.1599
Open
$0.166
Market Capitalization
$8.5M
Today's Volume
$4.9M
Revenue TTM
$8.1M
EBITDA
$-72.4M
Earnings Per Share (EPS)
$-1.32
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-166.9%

Global Institutional Holdings in Omega Therapeutics

  • Name

    Holdings %

  • Flagship Ventures Management, Inc.

    52.79%

  • FMR Inc

    10.95%

  • Harbourvest Partners, LLC

    6.34%

  • State Of Wisconsin Investment Board

    3.35%

  • Siren, L.L.C.

    2.39%

  • Vanguard Group Inc

    1.98%

Analyst Recommendation on Omega Therapeutics Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Omega Therapeutics(by analysts ranked 0 to 5 stars)

About Omega Therapeutics

Omega Therapeutics, Inc. operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. It also develops OTX-2002 for hepatocellular carcinoma; OTX-2101 for non-small cell lung cancer; omega epigenomic controllers (OEC) for inflammatory lung diseases, such as neutrophilic asthma, acute respiratory distress syndrome, dermatological, oncology, and rheumatological indications; OEC candidates for idiopathic pulmonary fibrosis; liver regeneration medicines; and OEC candidates for patients with diabetes and other conditions to treat corneal epithelial injury. In addition, the company develops OEC candidates for the treatment of alopecia, a disorder characterized by patches of non-scarring hair loss affecting the scalp and body. Omega Therapeutics, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. On February 10, 2025, Omega Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Organization
Omega Therapeutics
Employees
93
CEO
Dr. Kaan Certel Ph.D.
Industry
Miscellaneous

Key Management of Omega Therapeutics

NameTitle
Dr. Kaan Certel Ph.D.
President, CEO & Director
Dr. David A. Berry M.D., Ph.D.
Founder
Ms. Barbara Y. Chan CPA
Principal Financial Office, Principal Accounting Officer & Chief Accounting Officer
Dr. Jennifer Nelson Ph.D.
Chief Scientific Officer
Ms. Eva Stroynowski
Senior Vice President of Investor Relations & Corporate Affairs
Mr. Anthony Mullin
Chief People Officer
Mr. Charles O'Donnell Ph.D.
VP and Head of Computational Genomics & Data Sciences
Dr. Joe Newman Ph.D.
Senior Vice President of Early Discovery

Important FAQs about investing in OMGA Stock from India :

What is Omega Therapeutics share price today?

Omega Therapeutics share price today is as on at the close of the market. Omega Therapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Omega Therapeutics share?

Omega Therapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Omega Therapeutics stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Omega Therapeutics Stock (OMGA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Omega Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Omega Therapeutics Shares .

What is the minimum amount required to buy Omega Therapeutics Stock (OMGA) from India?

Indian investors can start investing in Omega Therapeutics (OMGA) shares with as little as ₹88.0712 or $1 (as of September 04, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹880.71 in Omega Therapeutics stock (as per the Rupee-Dollar exchange rate as on September 04, 2025). Learn more about fractional shares .

What are the returns that Omega Therapeutics has given to Indian investors in the last 5 years?

Omega Therapeutics stock has given 0.0% share price returns and 20.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?